Cargando…

β-blockers in septic shock: are we there yet?

Detalles Bibliográficos
Autores principales:	Cruz, Madalena Coutinho, Reis, Luís
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação de Medicina Intensiva Brasileira - AMIB 2017
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385978/ https://www.ncbi.nlm.nih.gov/pubmed/28444065 http://dx.doi.org/10.5935/0103-507X.20170001

Ejemplares similares

Glucose–insulin–potassium infusion in sepsis and septic shock: no hard evidence yet
por: van der Horst, Iwan CC, et al.
Publicado: (2003)

Should β-blockers be used in septic shock?
por: Lira, Alena, et al.
Publicado: (2014)

Ultrasound in Refractory Septic Shock: Have We Pitched and Pictured It Correctly Yet?
por: Nallasamy, Karthi, et al.
Publicado: (2022)

Can we predict septic shock in patients with hospital-acquired pneumonia?
por: de Lange, Dylan W, et al.
Publicado: (2005)

Should we start vasopressors very early in septic shock?
por: Ospina-Tascón, Gustavo A., et al.
Publicado: (2020)

Are we there yet? An update on transitional care in rheumatology
por: McDonagh, Janet E., et al.
Publicado: (2018)

Urgent start peritoneal dialysis: are we there yet?
por: Greenberg, Keiko I., et al.
Publicado: (2020)

Automatic detection of rib fractures: Are we there yet?
por: Blum, A, et al.
Publicado: (2020)

Newborn screening for neurodevelopmental diseases: Are we there yet?
por: Chung, Wendy K., et al.
Publicado: (2022)

Fluids and Early Vasopressors in the Management of Septic Shock: Do We Have the Right Answers Yet?
por: Carlos Sanchez, E., et al.
Publicado: (2023)

Beta-blockers in septic shock: What is new?
por: Lescroart, Mickael, et al.
Publicado: (2022)

Early detection of central lung cancer: are we there yet?
por: Musani, Ali I, et al.
Publicado: (2015)

Screening for type 1 diabetes: are we nearly there yet?
por: Narendran, Parth
Publicado: (2018)

Minimal residual disease in multiple myeloma: are we there yet?
por: Devarakonda, Srinivas, et al.
Publicado: (2020)

High-volume hemofiltration in septic shock
por: Rogiers, Peter
Publicado: (2005)

Modulation of macrophage polarity for treatment of acute pancreatitis: Are we there yet?
por: Sahay, Preeti, et al.
Publicado: (2020)

β1-blocker in sepsis
por: Hasegawa, Daisuke, et al.
Publicado: (2021)

Etomidate for intubation of patients who have sepsis or septic shock - where do we go from here?
por: Griesdale, Donald EG
Publicado: (2012)

Patient and Public Engagement in Integrated Knowledge Translation Research: Are we there yet?
por: Banner, Davina, et al.
Publicado: (2019)

Commentary: Fibrin glue in rhegmatogenous retinal detachment repair—Are we there yet?
por: Anshuman, Kumar, et al.
Publicado: (2019)

Commentary: Prognostication of uveal melanoma based on molecular diagnosis - Are we there yet?
por: Attiku, Yamini, et al.
Publicado: (2019)

Choice of vasopressor in septic shock: does it matter?
por: Patel, Gourang P, et al.
Publicado: (2007)

Leukocyte phenotyping to stratify septic shock patients
por: McDunn, Jonathan E, et al.
Publicado: (2009)

Live and let die: asymmetric dimethylarginine and septic shock
por: Böger, Rainer H
Publicado: (2006)

Dear vasopressin, where is your place in septic shock?
por: Duenser, Martin W, et al.
Publicado: (2005)

Rescue therapy in septic shock – is terlipressin the last frontier?
por: Leone, Marc, et al.
Publicado: (2006)

Is there a place for N-acetylcysteine in the treatment of septic shock?
por: Del Sorbo, Lorenzo, et al.
Publicado: (2004)

Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?
por: Rehberg, Sebastian, et al.
Publicado: (2009)

Coenzyme Q(10 )deficiency in septic shock patients
por: Dupic, Laurent, et al.
Publicado: (2011)

How much fluid resuscitation is optimal in septic shock?
por: Russell, James A
Publicado: (2012)

Septic shock and anesthesia: Much ado about nothing?
por: Khanna, Ashish K, et al.
Publicado: (2014)

Video-assisted laryngoscopic devices: Have we found the panacea for difficult airway yet?
por: Gupta, Anju
Publicado: (2017)

Microarrays and breast cancer clinical studies: forgetting what we have not yet learnt
por: Ahmed, Ahmed Ashour, et al.
Publicado: (2005)

Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination
por: Alexander, Neal D. E.
Publicado: (2015)

Using the diastolic shock index to determine when to promptly administer vasopressors in patients with septic shock
por: Ospina-Tascón, Gustavo A., et al.
Publicado: (2022)

Fluids in septic shock: too much of a good thing?
por: Groeneveld, AB Johan
Publicado: (2010)

Septic shock resuscitation: what goals and how to achieve them?
por: Jakob, Stephan M
Publicado: (2009)

Evaluation of left ventricular systolic function revisited in septic shock
por: Repessé, Xavier, et al.
Publicado: (2013)

The outcome of patients presenting to the emergency department with severe sepsis or septic shock
por: Rivers, Emanuel
Publicado: (2006)

Arterial pressure optimization in the treatment of septic shock: a complex puzzle
por: Jones, Alan E, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_bdock6elsjdm7lf6if8oaaq2dp